We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Proteus Digital Health Stock

Invest in or calculate the value of your shares in Proteus Digital Health or other pre-IPO companies through EquityZen's platform.

Get Started

Proteus Digital Health Stock (PRDH)

Digital health products

About Proteus Digital Health Stock

Founded

2001

Headquarters

Redwood City, CA, US

Total Funding

510M

Industries

Health Care, Mobile

Proteus Digital Health® is creating a new category of pharmaceuticals: Digital Medicines. Digital Medicines includes drugs that communicate when they’ve been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making and data analytics to serve the needs of doctors and health systems. The goal of Digital Medicines is to empower patients and their families, enable physicians and health systems to more effectively manage risk and ensure that outcomes are reliably achieved.

Investors in Proteus Digital Health

Discover investors in Proteus Digital Health stock and explore their portfolio companies

Proteus Digital Health Management

Leadership team at Proteus Digital Health

Co-Founder & Chief Executive Officer

Andrew Thompson

Co-Founder & Chief Medical Officer

George Savage, M.D.

Locked Features

Join now and verify your accreditation status to gain access to:

  • Proteus Digital Health current valuation
  • Proteus Digital Health stock price
  • Available deals in Proteus Digital Health and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Proteus Digital Health stock?

Accredited investors can buy pre-IPO stock in companies like Proteus Digital Health through EquityZen funds. These investments are made available by existing Proteus Digital Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Proteus Digital Health stock?

Shareholders can sell their Proteus Digital Health stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."